利伐沙班国内价格

Rivaroxaban tablets, jointly developed by Bayer and Janssen, are mainly used to treat adult patients undergoing elective hip or knee replacement surgery to prevent venous thrombosis (VTE).

Rivaroxaban is a highly selective, oral drug that directly inhibits factor xa. Routinely recommended dosage: Orally, rivaroxaban 10 mg, once daily. If the wound has stopped bleeding, the first medication should be administered between 6 and 10 hours after surgery. Can be taken with food or alone. Rivaroxaban 15 mg or 20 mg should be taken with food.

Prevention of deep vein thrombosis after hip replacement: 10 mg, once a day, 35 days of treatment.

Prevention of deep vein thrombosis after knee replacement: 10 mg, once a day, 12 days of treatment.

For the treatment of deep vein thrombosis and pulmonary embolism: The dose is 15 mg twice daily with meals for 21 days. For maintenance treatment and to reduce the risk of deep vein thrombosis and pulmonary embolism, the dose is 20 mg once daily with a meal.

For reducing the risk of stroke in non-valvular atrial fibrillation: 20 mg orally once daily with dinner. For patients who are underweight and older than 75 years old, 15 mg once a day can be used as appropriate.

In China, rivaroxaban tablets were approved for marketing by the State Food and Drug Administration in March 2009. What is the domestic price of rivaroxaban?

The price of rivaroxaban in China: Domestic rivaroxaban is the original drug produced by Bayer Pharma AG/Germany Bayer Pharmaceuticals. Specification: 10mg-5 tablets/box, priced at about 138$; Specification: 15mg-7 tablets/box, priced at about 199$; Specification: 20mg-7 tablets/box, priced at about 263$. In comparison, rivaroxaban sold abroad is cheaper, with specifications of 15mg*28 tablets and 20mg*28 tablets priced around $600. Please consult Medical Companion Travel for price details.